Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway.
Pharmaceutics. 2023 Feb 3;15(2):515. doi: 10.3390/pharmaceutics15020515.
Pharmaceutics. 2023.
PMID: 36839837
Free PMC article.
Review.
DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma.
Yagolovich AV, Isakova AA, Artykov AA, Vorontsova YV, Mazur DV, Antipova NV, Pavlyukov MS, Shakhparonov MI, Gileva AM, Markvicheva EA, Plotnikova EA, Pankratov AA, Kirpichnikov MP, Gasparian ME, Dolgikh DA.
Yagolovich AV, et al.
Int J Mol Sci. 2022 Oct 21;23(20):12687. doi: 10.3390/ijms232012687.
Int J Mol Sci. 2022.
PMID: 36293545
Free PMC article.
Item in Clipboard
Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells.
Yagolovich A, Kuskov A, Kulikov P, Kurbanova L, Bagrov D, Artykov A, Gasparian M, Sizova S, Oleinikov V, Gileva A, Kirpichnikov M, Dolgikh D, Markvicheva E.
Yagolovich A, et al.
Pharmaceutics. 2021 Sep 7;13(9):1413. doi: 10.3390/pharmaceutics13091413.
Pharmaceutics. 2021.
PMID: 34575490
Free PMC article.
Item in Clipboard
Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH-DR5-B with Dual VEGFR2 and DR5 Receptor Specificity.
Yagolovich AV, Artykov AA, Isakova AA, Vorontsova YV, Dolgikh DA, Kirpichnikov MP, Gasparian ME.
Yagolovich AV, et al.
Int J Mol Sci. 2022 May 24;23(11):5860. doi: 10.3390/ijms23115860.
Int J Mol Sci. 2022.
PMID: 35682540
Free PMC article.
Item in Clipboard
Doxorubicin-Loaded Polyelectrolyte Multilayer Capsules Modified with Antitumor DR5-Specific TRAIL Variant for Targeted Drug Delivery to Tumor Cells.
Gileva A, Trushina D, Yagolovich A, Gasparian M, Kurbanova L, Smirnov I, Burov S, Markvicheva E.
Gileva A, et al.
Nanomaterials (Basel). 2023 Feb 27;13(5):902. doi: 10.3390/nano13050902.
Nanomaterials (Basel). 2023.
PMID: 36903780
Free PMC article.
Item in Clipboard
Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.
Isakova A, Artykov A, Vorontsova Y, Dolgikh D, Kirpichnikov M, Gasparian M, Yagolovich A.
Isakova A, et al.
Mol Biotechnol. 2023 Apr;65(4):581-589. doi: 10.1007/s12033-022-00561-6. Epub 2022 Sep 12.
Mol Biotechnol. 2023.
PMID: 36094644
Item in Clipboard
Cite
Cite